All News Lexaria Bioscience Corp.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-13 EDT			5-day change	1st Jan Change
3.18 ^USD	-10.42%		-6.74%	+154.40%

05-08	Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study	CI
04-16	Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study	MT

Lexaria Begins Dosing of its Second GLP-1 Human Pilot Study	05-08	AQ
Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study	05-08	CI
Lexaria Bioscience : Corporate Presentation	05-06	PU
Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance	04-30	AQ
Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study	04-16	MT
Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study	04-16	CI
Lexaria Bioscience : Corporate Highlight Sheet	04-11	PU
Lexaria Bioscience Corp. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	04-09	CI
Lexaria Bioscience Corp. Receives New Patents in the Fields of Epilepsy and Anti-Viral Agents	04-02	CI
Lexaria Awarded New Patents	04-02	AQ
Lexaria Bioscience : Amendment of a Material Definitive Agreement - Form 8-K	03-21	PU
Lexaria to Present at The LD Micro Invitational XIV	03-21	NE
Lexaria Bioscience Names Nelson Cabatuan as Finance Chief	03-14	MT
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer	03-14	AQ
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer	03-14	CI
Lexaria Bioscience : Corporate Highlight Sheet	03-08	PU
Lexaria Awards Contract For Next GLP-1 Human Pilot Study	03-07	AQ
Sector Update: Health Care Stocks Retreating Late Afternoon	03-05	MT
Sector Update: Health Care	03-05	MT
Lexaria Bioscience to Start Diabetes, Weight Loss Animal Study; Shares Rise	03-05	MT

No results for this search